Evidence Synthesis
Divis Laboratories (DIVISLAB) has seen a 61.24% gross margin, accelerating from 36.66% in its last quarter.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 18 Sept 2026, 00:34
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
Divis Laboratories (DIVISLAB) has seen a 61.24% gross margin, accelerating from 36.66% in its last quarter.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 61.24 % | 36.66 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 36.66 % | 26.05 | ▲ |
| REVENUE_GROWTH_YOY | 27.8 % | 65.7 | ▼ |
| EPS_ACTUAL | 25.97 INR | 24.065 | ▲ |
| EPS_SURPRISE_PERCENT | 0.169 % | 0.034 | ▲ |
| PRICE_CHANGE_PERCENT | 1.802 % | — | - |
| DAILY_VOLUME | 4,94,113 shares | 4,77,909 | ▲ |
| CLOSE_PRICE | 9,323 INR | 9,158 | ▲ |
| NEWS_SENTIMENT_SCORE | 0.17 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 4 count | 10 | ▼ |
| TARGET_PRICE_PREMIUM | -9.4 % | — | - |